▲ SIGMATERMINAL Open Terminal →

Analyses / TSLA

TSLA Tesla Inc As of Aug 1, 2026
$311.21

Mega-cap EV leader at extreme valuation; FSD subscription upside vs. margin pressure and negative earnings revision.

Setup: Growth at elevated valuation; recovery narrative on FSD monetization Confidence: 55 Horizon: 6–12 months Risk: elevated Category: Large Cap Growth / Tech
🔒 Trade Plan — entry · target · stop
Entry Zone
$•••–•••
Target
$•••
Stop Loss
$•••
Risk / Reward
•.• : 1
Unlock the exact levels — free →

A free account reveals TSLA's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.

The Thesis

▲ Bull Case

FSD subscription tier ($99/mo, on pace for $1.8B annual revenue) unlocks recurring profit lever. 5Y revenue CAGR 24.6% and EPS growth 38.3% frame long-term TAM expansion. Tech moat in autonomous driving + energy (Megapack, battery) diversifies beyond autos. Current pullback (down 38% from 52w high) offers entry for believers in Musk vision.

▼ Bear Case

P/E 323x and P/S 12.96x are extreme even for growth; forward P/E barely cheaper. EPS down 33% YoY signals profit deterioration despite 5% revenue growth. Margins compressed (gross 18%, op 4.6%, net 4%) amid price wars and competition. P/FCF 197.6x unsustainable. Insider selling far outpaces buying (85 sells vs. 39 buys). Valuation leaves no room for miss.

Valuation

OVERVALUED on traditional metrics; justified only by extreme long-term TAM + autonomous upside — score 28/100

P/E 323x, P/S 12.96x, EV/EBITDA 101.6x, and P/FCF 197.6x place TSLA in the 99th percentile of valuations. Even against 24.6% 5Y revenue CAGR and 38.3% 5Y EPS growth, the multiples imply near-perfect execution and significant TAM expansion. YoY EPS decline of 33% breaks the growth narrative unless reversed in next 2–3 quarters. PEG unavailable; if EPS growth forecast is 15–20% next 12m, implied PEG would be 15–20x (elevated). Only thesis: FSD subscription scales to $2–3B+ run-rate and new business lines (energy, robotics) unlock 30%+ blended growth.

Technical Levels

Support · $297.38 (52-week low) · $301.97 (Today's low) · $308.85 (Previous close)

Resistance · $315.50 (Today's high) · $350.00 (Psychological level / prior consolidation) · $498.83 (52-week high)

RSI: Not available in payload

Financial Health

Score 72/100. Balance sheet liquidity is strong (current ratio 2.16x, quick ratio 1.55x). Book value ~$21.90/share vs. price $311.21 shows market prices in significant intangible value (technology, brand, IP). Debt metrics unavailable; assume moderate leverage given size and profitability. No major solvency red flags, but no upside surprise either.

Catalysts

Q2 2025 Earnings (FSD subscriber growth, margins, guidance revision)Next 2–3 weeks (typical Tesla schedule)high
Optimus (humanoid robot) demonstration or production milestoneH2 2025high
Energy business (Megapack) revenue acceleration / new contractsOngoing quarterly reportingmedium
FSD Full Self-Driving regulatory approvals (expand US rollout, international launch)2025–2026high
Macro / rate cycle changes (Fed cuts could support high-beta growth; rate hikes pressure valuation)Ongoinghigh

Risk Flags

P/E 323x and EV/EBITDA 101.6x are at tail extremes; no margin for execution stumble or macro slowdown.
EPS fell 33% YoY despite 5% revenue growth; margin compression is acute and may not reverse quickly.
PEG ratio unavailable; unable to assess growth-adjusted valuation. Forward P/E (323.9x) barely cheaper than trailing.
Insider activity: 85 sells vs. 39 buys; heavy net selling by insiders (net -418M shares sold). Bearish signal on conviction.
No dividend; all return depends on price appreciation. No downside cushion for patient income investors.
ROE, ROA, ROIC all null in provider data; capital efficiency metrics unavailable. Assess separately via latest 10-K.
Beta 1.82x amplifies broader market drawdowns; expect outsized volatility in risk-off environments.
RSI, sentiment, fundamentals (balance sheet, cash flow detail) not available in payload. Use caution on short-term technicals.

See TSLA's full trade plan — free

Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.

Unlock TSLA free →

Recent News

More Analyses

NVDA
NVIDIA Corp
AAPL
Apple Inc
MSFT
Microsoft Corp
AMZN
Amazon.com Inc
GOOGL
Alphabet Inc
META
Meta Platforms Inc

TSLA FAQ

Is TSLA a buy right now?

Tesla Inc's current read is a Growth at elevated valuation; recovery narrative on FSD monetization setup with 55 confidence over a 6–12 months horizon. Valuation: OVERVALUED on traditional metrics; justified only by extreme long-term TAM + autonomous upside. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.

Is TSLA overvalued?

OVERVALUED on traditional metrics; justified only by extreme long-term TAM + autonomous upside (valuation score 28/100). P/E 323x, P/S 12.96x, EV/EBITDA 101.6x, and P/FCF 197.6x place TSLA in the 99th percentile of valuations. Even against 24.6% 5Y revenue CAGR and 38.3% 5Y EPS growth, the multiples imply near-perfect execution and significant TAM expansion. YoY EPS decline of 33% breaks the growth narrative unless reversed in next 2–3 quarters. PEG unavailable; if EPS growth forecast is 15–20% next 12m, implied PEG would be 15–20x (elevated). Only thesis: FSD subscription scales to $2–3B+ run-rate and new business lines (energy, robotics) unlock 30%+ blended growth.

What are the risks of buying TSLA?

P/E 323x and P/S 12.96x are extreme even for growth; forward P/E barely cheaper. EPS down 33% YoY signals profit deterioration despite 5% revenue growth. Margins compressed (gross 18%, op 4.6%, net 4%) amid price wars and competition. P/FCF 197.6x unsustainable. Insider selling far outpaces buying (85 sells vs. 39 buys). Valuation leaves no room for miss.